(KSS) Kohl's - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5002551043
Stock: Apparel, Footwear, Accessories, Home Goods, Beauty
Total Rating 42
Risk 53
Buy Signal -1.27
| Risk 5d forecast | |
|---|---|
| Volatility | 72.4% |
| Relative Tail Risk | -16.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 16.65 |
| Character TTM | |
|---|---|
| Beta | 2.486 |
| Beta Downside | 2.979 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.01% |
| CAGR/Max DD | -0.14 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: KSS Kohl's March 04, 2026
Kohls Corporation (KSS) is a U.S. omnichannel retailer. The company sells apparel, footwear, accessories, beauty items, and home goods through both physical stores and its e-commerce platform.
Kohls offers products under proprietary brands like Apt. 9 and Sonoma Goods for Life, alongside licensed brands such as LC Lauren Conrad. The retail sector is characterized by intense competition and evolving consumer preferences, requiring companies to adapt their product offerings and sales channels.
Understanding a companys brand portfolio and distribution strategy is crucial for evaluating its market position. For further insights into KSSs financial performance and market data, consider exploring ValueRay.
Headlines to watch out for
- Consumer discretionary spending impacts apparel and home goods sales
- Inventory management affects profitability and markdown frequency
- E-commerce growth competes with brick-and-mortar store traffic
- Private label brand performance influences gross margins
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 271.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 7.35 > 1.0 |
| NWC/Revenue: 7.47% < 20% (prev 1.58%; Δ 5.89% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.38b > Net Income 271.0m |
| Net Debt (5.96b) to EBITDA (1.32b): 4.50 < 3 |
| Current Ratio: 1.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (115.0m) vs 12m ago 2.68% < -2% |
| Gross Margin: 36.06% > 18% (prev 0.36%; Δ 3.57k% > 0.5%) |
| Asset Turnover: 115.4% > 50% (prev 119.6%; Δ -4.28% > 0%) |
| Interest Coverage Ratio: 2.17 > 6 (EBITDA TTM 1.32b / Interest Expense TTM 288.0m) |
Altman Z'' 1.32
| A: 0.09 (Total Current Assets 3.69b - Total Current Liabilities 2.53b) / Total Assets 13.36b |
| B: 0.09 (Retained Earnings 1.22b / Total Assets 13.36b) |
| C: 0.05 (EBIT TTM 624.0m / Avg Total Assets 13.46b) |
| D: 0.13 (Book Value of Equity 1.22b / Total Liabilities 9.31b) |
| Altman-Z'' Score: 1.32 = BB |
Beneish M
| DSRI: none (Receivables none/159.0m, Revenue 15.53b/16.22b) |
| GMI: 0.99 (GM 36.06% / 35.86%) |
| AQI: 0.89 (AQ_t 0.03 / AQ_t-1 0.04) |
| SGI: 0.96 (Revenue 15.53b / 16.22b) |
| TATA: -0.08 (NI 271.0m - CFO 1.38b) / TA 13.36b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of KSS shares?
As of March 23, 2026, the stock is trading at USD 12.43 with a total of 10,065,925 shares traded.
Over the past week, the price has changed by -3.73%, over one month by -30.80%, over three months by -42.52% and over the past year by +37.11%.
Over the past week, the price has changed by -3.73%, over one month by -30.80%, over three months by -42.52% and over the past year by +37.11%.
Is KSS a buy, sell or hold?
Kohl's has received a consensus analysts rating of 2.50.
Therefor, it is recommend to sell KSS.
- StrongBuy: 1
- Buy: 0
- Hold: 7
- Sell: 6
- StrongSell: 2
What are the forecasts/targets for the KSS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.5 | 40.5% |
| Analysts Target Price | 17.5 | 40.5% |
KSS Fundamental Data Overview March 23, 2026
P/E Trailing = 5.2227
P/E Forward = 8.7566
P/S = 0.0898
P/B = 0.3445
P/EG = 0.3218
Revenue TTM = 15.53b USD
EBIT TTM = 624.0m USD
EBITDA TTM = 1.32b USD
Long Term Debt = 1.52b USD (from longTermDebt, two quarters ago)
Short Term Debt = 179.0m USD (from shortTermDebt, last quarter)
Debt = 6.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.96b USD (from netDebt column, last quarter)
Enterprise Value = 7.35b USD (1.39b + Debt 6.63b - CCE 674.0m)
Interest Coverage Ratio = 2.17 (Ebit TTM 624.0m / Interest Expense TTM 288.0m)
EV/FCF = 6.33x (Enterprise Value 7.35b / FCF TTM 1.16b)
FCF Yield = 15.81% (FCF TTM 1.16b / Enterprise Value 7.35b)
FCF Margin = 7.48% (FCF TTM 1.16b / Revenue TTM 15.53b)
Net Margin = 1.75% (Net Income TTM 271.0m / Revenue TTM 15.53b)
Gross Margin = 36.06% ((Revenue TTM 15.53b - Cost of Revenue TTM 9.93b) / Revenue TTM)
Gross Margin QoQ = 32.38% (prev 37.48%)
Tobins Q-Ratio = 0.55 (Enterprise Value 7.35b / Total Assets 13.36b)
Interest Expense / Debt = 0.89% (Interest Expense 59.0m / Debt 6.63b)
Taxrate = 18.30% (28.0m / 153.0m)
NOPAT = 509.8m (EBIT 624.0m * (1 - 18.30%))
Current Ratio = 1.46 (Total Current Assets 3.69b / Total Current Liabilities 2.53b)
Debt / Equity = 1.64 (Debt 6.63b / totalStockholderEquity, last quarter 4.05b)
Debt / EBITDA = 4.50 (Net Debt 5.96b / EBITDA 1.32b)
Debt / FCF = 5.13 (Net Debt 5.96b / FCF TTM 1.16b)
Total Stockholder Equity = 3.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.01% (Net Income 271.0m / Total Assets 13.36b)
RoE = 6.91% (Net Income TTM 271.0m / Total Stockholder Equity 3.92b)
RoCE = 11.46% (EBIT 624.0m / Capital Employed (Equity 3.92b + L.T.Debt 1.52b))
RoIC = 9.07% (NOPAT 509.8m / Invested Capital 5.62b)
WACC = 3.16% (E(1.39b)/V(8.02b) * Re(14.73%) + D(6.63b)/V(8.02b) * Rd(0.89%) * (1-Tc(0.18)))
Discount Rate = 14.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 1.33%
[DCF] Terminal Value 80.82% ; FCFF base≈770.0m ; Y1≈505.5m ; Y5≈230.6m
[DCF] Fair Price = 12.41 (EV 7.35b - Net Debt 5.96b = Equity 1.39b / Shares 112.2m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 17.73 | EPS CAGR: 83.43% | SUE: 0.48 | # QB: 0
Revenue Correlation: -9.32 | Revenue CAGR: 9.23% | SUE: 1.44 | # QB: 1
EPS next Quarter (2026-04-30): EPS=-0.22 | Chg7d=+0.000 | Chg30d=-0.220 | Revisions Net=-1 | Analysts=2
EPS current Year (2027-01-31): EPS=1.52 | Chg7d=+0.000 | Chg30d=+0.097 | Revisions Net=+1 | Growth EPS=-36.3% | Growth Revenue=+0.8%
EPS next Year (2028-01-31): EPS=1.77 | Chg7d=+0.000 | Chg30d=-0.113 | Revisions Net=-1 | Growth EPS=+16.5% | Growth Revenue=+0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.4% (Discount Rate 14.7% - Earnings Yield 19.1%)
[Growth] Growth Spread = +3.7% (Analyst -0.7% - Implied -4.4%)
P/E Forward = 8.7566
P/S = 0.0898
P/B = 0.3445
P/EG = 0.3218
Revenue TTM = 15.53b USD
EBIT TTM = 624.0m USD
EBITDA TTM = 1.32b USD
Long Term Debt = 1.52b USD (from longTermDebt, two quarters ago)
Short Term Debt = 179.0m USD (from shortTermDebt, last quarter)
Debt = 6.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.96b USD (from netDebt column, last quarter)
Enterprise Value = 7.35b USD (1.39b + Debt 6.63b - CCE 674.0m)
Interest Coverage Ratio = 2.17 (Ebit TTM 624.0m / Interest Expense TTM 288.0m)
EV/FCF = 6.33x (Enterprise Value 7.35b / FCF TTM 1.16b)
FCF Yield = 15.81% (FCF TTM 1.16b / Enterprise Value 7.35b)
FCF Margin = 7.48% (FCF TTM 1.16b / Revenue TTM 15.53b)
Net Margin = 1.75% (Net Income TTM 271.0m / Revenue TTM 15.53b)
Gross Margin = 36.06% ((Revenue TTM 15.53b - Cost of Revenue TTM 9.93b) / Revenue TTM)
Gross Margin QoQ = 32.38% (prev 37.48%)
Tobins Q-Ratio = 0.55 (Enterprise Value 7.35b / Total Assets 13.36b)
Interest Expense / Debt = 0.89% (Interest Expense 59.0m / Debt 6.63b)
Taxrate = 18.30% (28.0m / 153.0m)
NOPAT = 509.8m (EBIT 624.0m * (1 - 18.30%))
Current Ratio = 1.46 (Total Current Assets 3.69b / Total Current Liabilities 2.53b)
Debt / Equity = 1.64 (Debt 6.63b / totalStockholderEquity, last quarter 4.05b)
Debt / EBITDA = 4.50 (Net Debt 5.96b / EBITDA 1.32b)
Debt / FCF = 5.13 (Net Debt 5.96b / FCF TTM 1.16b)
Total Stockholder Equity = 3.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.01% (Net Income 271.0m / Total Assets 13.36b)
RoE = 6.91% (Net Income TTM 271.0m / Total Stockholder Equity 3.92b)
RoCE = 11.46% (EBIT 624.0m / Capital Employed (Equity 3.92b + L.T.Debt 1.52b))
RoIC = 9.07% (NOPAT 509.8m / Invested Capital 5.62b)
WACC = 3.16% (E(1.39b)/V(8.02b) * Re(14.73%) + D(6.63b)/V(8.02b) * Rd(0.89%) * (1-Tc(0.18)))
Discount Rate = 14.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 1.33%
[DCF] Terminal Value 80.82% ; FCFF base≈770.0m ; Y1≈505.5m ; Y5≈230.6m
[DCF] Fair Price = 12.41 (EV 7.35b - Net Debt 5.96b = Equity 1.39b / Shares 112.2m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 17.73 | EPS CAGR: 83.43% | SUE: 0.48 | # QB: 0
Revenue Correlation: -9.32 | Revenue CAGR: 9.23% | SUE: 1.44 | # QB: 1
EPS next Quarter (2026-04-30): EPS=-0.22 | Chg7d=+0.000 | Chg30d=-0.220 | Revisions Net=-1 | Analysts=2
EPS current Year (2027-01-31): EPS=1.52 | Chg7d=+0.000 | Chg30d=+0.097 | Revisions Net=+1 | Growth EPS=-36.3% | Growth Revenue=+0.8%
EPS next Year (2028-01-31): EPS=1.77 | Chg7d=+0.000 | Chg30d=-0.113 | Revisions Net=-1 | Growth EPS=+16.5% | Growth Revenue=+0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.4% (Discount Rate 14.7% - Earnings Yield 19.1%)
[Growth] Growth Spread = +3.7% (Analyst -0.7% - Implied -4.4%)